武汉云克隆科技股份有限公司

亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)

Multiplex Assay Kit for Cyclophilin A (CYPA) ,etc. by FLIA (Flow Luminescence Immunoassay)

PPIA; CyP-A; CYPH; Peptidylprolyl Isomerase A; Peptidyl-Prolyl Isomerase A; Peptidyl-prolyl cis-trans isomerase A; Cyclosporin A-binding protein

（注：单次混测多因子不超过8个指标 ）

  • 亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)产品包装(模拟)
  • 亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)产品包装(模拟)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)，经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制，不可能完成对所有相关或相似物质交叉反应检测，因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)（加标样品），重复测定并计算其均值，回收率为测定值与理论值的比率。

样本回收率范围(%)平均回收率(%)
serum(n=5)88-9591
EDTA plasma(n=5)93-10196
heparin plasma(n=5)78-10190

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差：取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次，分别计算不同浓度样本的平均值及SD值。
批间差：选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定，每个样本使用同一试剂盒重复测定8次，分别计算不同浓度样本的平均值及SD值。
批内差： CV<10%
批间差： CV<12%

线性

在定值血清及血浆样本内加入适量的亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)，并倍比稀释成1:2，1:4，1:8，1:16的待测样本，线性范围即为稀释后样本中亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)含量的测定值与理论值的比率。

样本1:21:41:81:16
serum(n=5)81-89%87-94%83-103%89-96%
EDTA plasma(n=5)86-97%96-105%78-103%78-89%
heparin plasma(n=5)90-99%82-97%86-99%79-104%

稳定性

经测定，试剂盒在有效期内按推荐温度保存，其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响，实验室的环境条件需尽量保持一致，尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本准备；
2. 加样（标准品、样本、磁珠）标准品或样本100μL及磁珠10μL，
    37°C酶标板振荡器孵育90分钟；
3. 磁吸甩干，加检测溶液A100μL，37°C酶标板振荡器孵育60分钟；
4. 磁吸洗板3次；
5. 加检测溶液B100μL，37°C振动孵育30分钟；
6. 磁吸洗板3次；
7. 加鞘液100μL，旋涡震荡2分钟后读数。

实验原理

将亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)抗体包被于磁珠，制成固相载体，向微孔中分别加入标准品或标本以及磁珠，其中的亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)与连接于固相载体上的抗体结合，然后加入生物素化的亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)抗体，将未结合的生物素化抗体洗净后，加入PE标记的亲和素，再次彻底洗涤后即可上机读数。MFI值和样品中的亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)呈正相关。

赠品

相关产品

编号适用物种：Homo sapiens (Human，人)应用(仅供研究使用，不用于临床诊断！)
RPA979Hu01亲环素A(CYPA)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
CPA979Hu21亲环素A(CYPA)卵白蛋白偶联物Immunogen; SDS-PAGE; WB.
PAA979Hu08亲环素A(CYPA)多克隆抗体WB; IHC; ICC; IP.
PAA979Hu01亲环素A(CYPA)多克隆抗体WB; IHC; ICC/IF;FCM
LAA979Hu81亲环素A(CYPA)多克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
LAA979Hu71亲环素A(CYPA)多克隆抗体(生物素标记)WB; IHC; ICC.
MAA979Hu22亲环素A(CYPA)单克隆抗体WB,IHC,ICC/IF
MAA979Hu23亲环素A(CYPA)单克隆抗体WB; IHC; ICC; IP.
MAA979Hu24亲环素A(CYPA)单克隆抗体WB; IHC; ICC; IP.
MAA979Hu25亲环素A(CYPA)单克隆抗体WB; IHC; ICC; IP.
MAA979Hu21亲环素A(CYPA)单克隆抗体WB; IHC
FAA979Hu02抗亲环素A(CYPA)单克隆抗体Flow cytometry.
FAA979Hu06抗亲环素A(CYPA)单克隆抗体Flow cytometry.
FAA979Hu08抗亲环素A(CYPA)单克隆抗体Flow cytometry.
LAA979Hu72亲环素A(CYPA)单克隆抗体(生物素标记)WB; IHC; ICC.
SEA979Hu亲环素A(CYPA)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA979Hu亲环素A(CYPA)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.
PSA979Hu01亲环素A(CYPA)抗体对ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSA979Hu01亲环素A(CYPA)检测试剂盒DIY材料(酶联免疫吸附试验法)Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志参考文献
AtherosclerosisEMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation[PubMed: 19758589]
BiomarkersCyclophilin-A: a novel biomarker for untreated male essential hypertension[Pubmed: 24164594]
Cardiovascular DiabetologyPlasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease[Pubmed:24502618]
International Journal of Biological SciencesDecrease in Plasma Cyclophilin A Concentration at 1 Month after Myocardial Infarction Predicts Better Left Ventricular Performance and Synchronicity at 6 Months: A Pilot Study in Patients with ST Elevation Myocardial Infarction[Pubmed:25552928]
MedicineCyclophilin A in Ruptured Intracranial Aneurysm[PubMed: 26426668]
Mol Cell BiochemPPIA rs6850: A> G single-nucleotide polymorphism is associated with raised plasma cyclophilin A levels in patients with coronary artery disease[PubMed: 26702934]
Medicine (Baltimore)Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus[PubMed: 26496315]
International Journal of CardiologyCyclophilin A modulates bone marrow-derived CD117(+) cells and enhances ischemia-induced angiogenesisvia the SDF-1/CXCR4 axis.[Pubmed:27057951]
Clinica Chimica ActaNovel findings of secreted cyclophilin A in diabetic nephropathy and its association with renal protection of dipeptidyl peptidase 4 inhibitor[pubmed:27823952]
Cardiovascular DiabetologyCyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus.[pubmed:27809851]
Clinical ScienceMetformin attenuates effects of cyclophilin A on macrophages, reduces lipid uptake and secretion of cytokines by repressing decreased AMPK activity[Pubmed:29382697]
Journal of Molecular HistologyCyclophilin a increases CD68 cell infiltration in rat experimental periodontitis[Pubmed:29318411]
Free Radical ResearchCyclophilin A and CD147 associate with progression of diabetic nephropathy[Pubmed: 30572748]
The Kaohsiung Journal of Medical SciencesAssociation of cyclophilin A level and pulse pressure in predicting recurrence of cerebral infarction[Pubmed: 31670477]
Cells.Cyclophilin A/EMMPRIN Axis Is Involved in Pro-Fibrotic Processes Associated with Thoracic Aortic Aneurysm of Marfan Syndrome Patients[Pubmed: 31936351]
JAMA NeurologyAPPENDIX A: Relationship between cyclophilin A levels and matrix metalloproteinase-9 activity in cerebrospinal fluid of cognitively normal apolipoprotein E4 carriers …[Pubmed: 24030206]
Menoufia Medical JournalUrinary podocalyxin and cyclophilin A: markers for early detection of type 2 diabetic nephropathy[]
ToxinsEvaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy[34437430]
Cell Death & DiseaseProteomic analysis reveals USP7 as a novel regulator of palmitic acid-induced hepatocellular carcinoma cell death[Pubmed:35732625]